Form 4: Elanco Animal Health CEO Jeffrey Simmons Reports Acquisition of Deferred Stock Units

Elanco Animal Health's CEO, Jeffrey Simmons, reported the acquisition of deferred stock units on July 12, 2024.

Summary

• On July 12, 2024, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., acquired deferred stock units.
• The transaction involved 200.5243 deferred stock units, each representing the right to receive one share of Elanco's common stock or the cash equivalent.
• The price per unit was $13.81.
• Following the reported transaction, Simmons directly owns 2,506.7083 deferred stock units.
• These deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of stock units by the CEO is generally a positive sign, but it's a standard practice.

Positives

• The acquisition of deferred stock units by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.

Industry Context

Executive compensation in the form of stock and deferred stock units is a common practice in the animal health industry to align management's interests with those of shareholders.

Comparison to Industry Standards

• Comparing Elanco's executive compensation structure to peers like Zoetis or Merck Animal Health would provide a benchmark for assessing the competitiveness and alignment of incentives.
• Deferred stock units are a fairly standard component of executive compensation packages across the pharmaceutical and animal health industries.
• The specific terms of Elanco's Executive Deferral and Stock Match Plan would need to be compared to similar plans at competitor companies to determine its relative attractiveness and impact on executive motivation.

Stakeholder Impact

• The acquisition of deferred stock units by the CEO aligns his interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates